Clinical Trials Directory

Trials / Completed

CompletedNCT05290246

TRE in Type 2 Diabetes (See Food Study 3)

TRE in Type 2 Diabetes Mellitus (See Food Study 3)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
115 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential burden on quality of life. In contrast to intentionally restricting calories, time restricted eating (TRE), presents a simplified view of eating focused on restricting the eating window, which allows ad libitum intake per a person's dietary preferences during a daily fixed eating window. This study proposes a 24 week feasibility study to test if TRE is a viable alternative to Caloric Restriction in improving glycemic measures while accounting for weight loss in overweight/obese patients \[BMI:25-45 kg/m2\] with metformin-only treated Type 2 diabetes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTime restricted eatingLimiting daily eating time to an 8 hour window
BEHAVIORALCaloric reductionCut caloric intake by 15%

Timeline

Start date
2022-05-27
Primary completion
2025-12-12
Completion
2026-03-23
First posted
2022-03-22
Last updated
2026-04-14
Results posted
2026-03-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05290246. Inclusion in this directory is not an endorsement.